STAAR SURGICAL CO

STAAR SURGICAL CO (STAA) is a US-listed equity tracked across major market indices. Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.

The company reports trailing twelve-month revenue of $93.52M and net income of $5.21M. Key metrics include a return on equity of 1.5%, a debt-to-equity ratio of 0.28.

FINOTAUR provides free research summaries, news aggregation, and fundamentals for STAA to support both active traders and long-term investors.